Doximity reported that over 190 health systems have adopted its AI suite, marking a growth from 165 clients in a single quarter. Among these users are 10 of the top 20 hospitals in the United States. Furthermore, 16 of the 20 largest pharmaceutical companies have purchased the company’s AI Search advertising product.
The platform is transitioning from automated documentation to clinical decision support. This move aims to capture a portion of the $14 billion annual pharmaceutical search advertising market. The AI Search product has already achieved eight-figure bookings, with revenue expected to grow gradually through 2027.
NewYork-Presbyterian has integrated these tools across 10 hospitals and hundreds of locations. Additionally, UC San Diego Health adopted a patient context feature that reduces physician prompt length from an average of 24 words to 12 words by automatically retrieving relevant patient data.
To address risks in clinical decision support, Doximity launched DoseCheck and integrated medical reference content from Wolters Kluwer’s UpToDate. The company previously identified that 2.3% of responses in its tested models contained incorrect medication dosing recommendations, with 44% of those errors classified as serious or potentially lethal.
